Metraipolis › archive › dc_0806190bc50e

Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall… — Europe PMC PMID:32542231

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32542231
DOI
10.36959/739/525
License (as archived)
solo-consultazione
Archived
2026-10-07T15:51:15.883Z
SHA-256 of the archived text
859053f0db3d8ab7463f1bc38054497ecfe3fb953b9fd6ede9987766ffa772ea
Stable URL of this page
https://metraipolis.com/documento/dc_0806190bc50e

How to cite

Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall… — Europe PMC PMID:32542231 — Europe PMC (en), https://europepmc.org/article/MED/32542231 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0806190bc50e (Metraipolis archive dc_0806190bc50e, sha256 859053f0db3d8ab7463f1bc38054497ecfe3fb953b9fd6ede9987766ffa772ea)
BibTeX
@misc{dc0806190bc50e,
  title = {Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall… — Europe PMC PMID:32542231},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32542231},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0806190bc50e; sha256 859053f0db3d8ab7463f1bc38054497ecfe3fb953b9fd6ede9987766ffa772ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/32542231. Agents can read the archived copy with the MCP tool read_document.